Project information
Vliv farmakogenetických a farmakokinetických faktorů na účinnost a bezpečnost terapie prvních epizod schizofrenie
- Project Identification
- NS9676
- Project Period
- 1/2009 - 12/2011
- Investor / Pogramme / Project type
-
Ministry of Health of the CR
- Departmental Programme of Research and Development - MH II from 2008 to 2011
- MU Faculty or unit
- Faculty of Medicine
- Cooperating Organization
-
University Hospital Brno-Bohunice
- Responsible person prof. MUDr. Tomáš Kašpárek, Ph.D.
Publications
Total number of publications: 18
2013
-
Alternative Reliable Method for Cytochrome P450 2D6 Poor Metabolizers Genotyping
Molecular Biotechnology, year: 2013, volume: 53, edition: 1, DOI
2012
-
Farmakogenetika v psychiatrii
Postgraduální medicína, year: 2012, volume: 2012, edition: 14
-
Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone
Neuroendocrinology Letters, year: 2012, volume: 33, edition: 2
-
Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, year: 2012, volume: 37, edition: 4, DOI
2011
-
Aktivita CYP2D6 u pacientů léčených risperidonem
Česká a slovenská psychiatrie, year: 2011, volume: 107, edition: 6
-
CYP2D6 phenotype and genotype determination with respect to prediction of therapeutic response in first episode schizophrenia treatment
Year: 2011, type: Conference abstract
-
CYP2D6 phenotyping in clinical practice: serum or urine dextromethorphan/dextrorphan metabolic ratio?
17th International Conference on Cytochrome P450, year: 2011
-
Vplyv atypických antipsychotík na sexuálnu funkciu u mužov
Psychiatrie pro praxi, year: 2011, volume: 12, edition: 1
2010
-
Correlation of serum and urine dextromethorphan/dextrorphan metabolic ratio in CYP2D6 phenotyping
Year: 2010, type: Conference abstract
-
Detection of the polymorphisms in the CYP2D6 gene and their influence on metabolism of drugs
Year: 2010, type: Conference abstract